Nasal Delivery Device Treats Acute Epileptic Seizures
|
By HospiMedica International staff writers Posted on 31 Dec 2019 |
|
Image: The Aptar Unidose Liquid System (Photo courtesy of Aptar)
A nasal rescue system offers a ready-to-use, one-step option to treat acute repetitive seizures in those with epilepsy.
The Aptar (Crystal Lake, IL, USA) Unidose Liquid System is designed to deliver a small, but precise amount of liquid midazolam-- a benzodiazepine commonly used for anesthesia, procedural sedation, and severe agitation--intra-nasally, with high deposition in targeted areas of the nose-to-brain pathway, thus allowing the therapeutic compound to enter the central nervous system (CNS) rapidly. To deliver the100 µl liquid dose, a small plunger on the bottom of the device is pressed, releasing the drug in a single spray into the nostril, where it can be absorbed via the nasal mucosa.
The system is ready-to-use, does not require priming, and can be easily used with one hand, from any direction, even by a bystander with little training. In order to help patients and caretakers develop a familiarity with the device and its use ahead of a potential emergency, they can practice administering the drug with a trainer device that mimics the actual system. The trainer was developed by Aptar subsidiary Noble International (Orlando, FL, USA).
“The launch of our Unidose System nasal rescue treatment for seizure activity once again demonstrates Aptar Pharma’s ability to help our customers develop and launch complex treatments,” said Gael Touya, president of Aptar Pharma. “When we combine our nasal systems’ capabilities with Noble’s training devices for onboarding, we bring added value to our customers and further convenience for patients and consumers worldwide.”
The olfactory epithelium, situated in the upper posterior part of the nasal cavity, covers approximately 10 cm2 of the human nasal cavity. The nerve cells of the olfactory epithelium project into the olfactory bulb of the brain, which provides a direct connection between the brain and the external environment. The transfer of drugs to the brain from the blood circulation is normally hindered by the blood–brain barrier (BBB); however, if drug substances can be transferred along the olfactory nerve cells, they can bypass the BBB and enter the brain directly.
Related Links:
Aptar
Noble International
The Aptar (Crystal Lake, IL, USA) Unidose Liquid System is designed to deliver a small, but precise amount of liquid midazolam-- a benzodiazepine commonly used for anesthesia, procedural sedation, and severe agitation--intra-nasally, with high deposition in targeted areas of the nose-to-brain pathway, thus allowing the therapeutic compound to enter the central nervous system (CNS) rapidly. To deliver the100 µl liquid dose, a small plunger on the bottom of the device is pressed, releasing the drug in a single spray into the nostril, where it can be absorbed via the nasal mucosa.
The system is ready-to-use, does not require priming, and can be easily used with one hand, from any direction, even by a bystander with little training. In order to help patients and caretakers develop a familiarity with the device and its use ahead of a potential emergency, they can practice administering the drug with a trainer device that mimics the actual system. The trainer was developed by Aptar subsidiary Noble International (Orlando, FL, USA).
“The launch of our Unidose System nasal rescue treatment for seizure activity once again demonstrates Aptar Pharma’s ability to help our customers develop and launch complex treatments,” said Gael Touya, president of Aptar Pharma. “When we combine our nasal systems’ capabilities with Noble’s training devices for onboarding, we bring added value to our customers and further convenience for patients and consumers worldwide.”
The olfactory epithelium, situated in the upper posterior part of the nasal cavity, covers approximately 10 cm2 of the human nasal cavity. The nerve cells of the olfactory epithelium project into the olfactory bulb of the brain, which provides a direct connection between the brain and the external environment. The transfer of drugs to the brain from the blood circulation is normally hindered by the blood–brain barrier (BBB); however, if drug substances can be transferred along the olfactory nerve cells, they can bypass the BBB and enter the brain directly.
Related Links:
Aptar
Noble International
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Patient Preoperative Skin Preparation
BD ChloraPrep
New
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Latest Critical Care News
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
- Algorithm Allows Paramedics to Predict Brain Damage Risk After Cardiac Arrest
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
Surgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
